Pediatricians' offices, children's hospitals, urgent care centers and emergency rooms across the United States are being overwhelmed by an early, heavy surge of respiratory syncytial virus (RSV) among infants and young children.
Oct 25, 2022
0
5
A new analysis of how the immune system responds to both older and newer investigational vaccines for respiratory syncytial virus—RSV—will help inform the ultimate translation of an immunization from the laboratory to ...
Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the ...
Nov 4, 2015
0
185
While multiple effective COVID-19 vaccines were developed with astonishing speed, it has been more than 40 years since University of Rochester alumnus Michael Gottlieb, M.D., first described the disease that became known ...
May 27, 2022
0
13
Close interactions with infectious disease set both University of California, Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor of Biomolecular Engineering Rebecca DuBois on the path of studying respiratory ...
Mar 10, 2022
0
85
It seems like whenever there's a party, someone goes home sick.
Dec 22, 2022
0
2
Half of U.S. adults report being sickened with COVID-19 at some point during the pandemic, with only a fraction saying they received an official medical diagnosis of the respiratory infection, according to a new survey by ...
Dec 12, 2022
0
33
As SARS-CoV-2 has the potential to mutate, it is important to check the efficacy of current diagnostic tests, say York University researchers, who found seven out of 27 methods had potential sequence mismatch issues that ...
Jun 10, 2020
0
154
New tests of a recently approved vaccine for respiratory syncytial virus—RSV—show the shot remains effective against a range of variants producing potent antibody responses against current and past strains, and may even ...
Pharmaceutical giant Pfizer on Thursday announced positive results in the elderly for a vaccine against respiratory syncytial virus (RSV), for which there are currently no authorized shots.
Aug 25, 2022
0
21
